Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Takeda Pharmaceutical has the lowest figure of the 61 pharmaceutical companies ranked by short interest, at 0.10%, followed by AstraZeneca (0.20%) and Novartis (0.24%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Takeda Pharmaceutical0.10%
- Median
- 5.47%
- Combined market value
- CZK 112.84T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Takeda PharmaceuticalTAK · Health Care | 0.10% | CZK 1.52T | CZK 474.63 | 1.39% down | 54% up | ||
| 2 | AstraZenecaAZN · Health Care | 0.20% | CZK 6.17T | CZK 3,980.16 | 1.82% down | 2% up | ||
| 3 | NovartisNVS · Health Care | 0.24% | CZK 6.53T | CZK 3,460.16 | 2.23% down | 25% up | ||
| 4 | SanofiSNY · Health Care | 0.51% | CZK 2.52T | CZK 1,051.11 | 0.57% down | 4% down | ||
| 5 | Johnson & JohnsonJNJ · Health Care | 0.71% | CZK 14.69T | CZK 6,100.18 | 1.59% down | 38% up | ||
| 6 | GSKGSK · Health Care | 0.81% | CZK 2.17T | CZK 1,082.25 | 1.18% down | 6% up | ||
| 7 | Eli LillyLLY · Health Care | 0.81% | CZK 27.52T | CZK 30,891.78 | 1.88% down | 35% up | ||
| 8 | Novo NordiskNVO · Health Care | 0.87% | CZK 3.87T | CZK 879.08 | 2.89% down | 17% down | ||
| 9 | GrifolsGRFS · Health Care | 0.88% | CZK 127.5B | CZK 187.38 | 2.38% down | 1% up | ||
| 10 | AbbVieABBV · Health Care | 0.89% | CZK 11.28T | CZK 6,380.51 | 2.03% down | 26% up | ||
| 11 | Merck & CoMRK · Health Care | 1.08% | CZK 7.56T | CZK 3,064.82 | 3.89% down | 51% up | ||
| 12 | Abbott LaboratoriesABT · Health Care | 1.10% | CZK 4.02T | CZK 2,323.97 | 0.21% down | 17% down | ||
| 13 | BeOne MedicinesONC · Health Care | 1.40% | CZK 1.03T | CZK 8,988.52 | 2.21% down | 17% up | ||
| 14 | GenmabGMAB · Health Care | 1.57% | CZK 703.7B | CZK 1,141.19 | 1.25% down | 70% up | ||
| 15 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | CZK 3.03T | CZK 11,966.82 | 0.72% up | 27% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | CZK 2.17T | CZK 21,022.51 | 1.31% down | 36% up | ||
| 17 | Royalty PharmaRPRX · Health Care | 2.27% | CZK 886.4B | CZK 1,541.64 | 0.92% up | 78% up | ||
| 18 | Bristol-Myers SquibbBMY · Health Care | 2.29% | CZK 2.72T | CZK 1,332.69 | 2.33% down | 34% up | ||
| 19 | PfizerPFE · Health Care | 2.36% | CZK 3.56T | CZK 624.64 | 1.35% down | 14% up | ||
| 20 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | CZK 1.09T | CZK 935.57 | 1.30% down | 74% up | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | CZK 278.8B | CZK 334.39 | 1.66% up | 5% up | ||
| 22 | ViatrisVTRS · Health Care | 3.07% | CZK 525.6B | CZK 458.50 | 0.81% up | 96% up | ||
| 23 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | CZK 170.3B | CZK 488.75 | 4.05% up | 83% up | ||
| 24 | Belite BioBLTE · Health Care | 3.40% | CZK 141.6B | CZK 3,485.29 | 0.64% down | 31% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | CZK 444.5B | CZK 3,318.37 | 4.66% down | 66% down | ||
| 26 | ZoetisZTS · Health Care | 4.12% | CZK 772.7B | CZK 1,901.61 | 2.42% up | 29% down | ||
| 27 | United TherapeuticsUTHR · Health Care | 4.31% | CZK 550.5B | CZK 12,926.75 | 0.49% down | 23% up | ||
| 28 | Ascendis PharmaASND · Health Care | 4.57% | CZK 395B | CZK 6,022.33 | 0.15% down | 28% up | ||
| 29 | ABIVAXABVX · Health Care | 4.70% | CZK 162.8B | CZK 1,859.13 | 1.81% up | 27% down | ||
| 30 | Summit TherapeuticsSMMT · Health Care | 5.28% | CZK 187.3B | CZK 234.20 | 1.31% down | 36% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | CZK 166.2B | CZK 2,114.94 | 0.02% down | 126% up | ||
| 32 | Legend BiotechLEGN · Health Care | 6.13% | CZK 69.7B | CZK 359.42 | 0.31% up | 42% down | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | 6.20% | CZK 156.4B | CZK 2,972.63 | 1.69% down | 7% down | ||
| 34 | Roivant SciencesROIV · Health Care | 6.28% | CZK 618.5B | CZK 853.61 | 0.85% down | 90% up | ||
| 35 | InsmedINSM · Health Care | 6.42% | CZK 587B | CZK 2,675.72 | 1.28% down | 40% down | ||
| 36 | Elanco Animal HealthELAN · Health Care | 6.59% | CZK 299.2B | CZK 598.51 | 4.10% up | 20% up | ||
| 37 | Definium TherapeuticsDFTX · Health Care | 7.02% | CZK 86.9B | CZK 634.98 | 2.83% down | 169% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | CZK 261.9B | CZK 1,352.04 | 3.90% up | 11% up | ||
| 39 | VeradermicsMANE · Health Care | 8.03% | CZK 116.6B | CZK 2,763.68 | 1.10% down | 233% up | ||
| 40 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | CZK 136B | CZK 962.15 | 0.63% up | 10% up | ||
| 41 | Corcept TherapeuticsCORT · Health Care | 8.34% | CZK 165B | CZK 1,507.72 | 3.25% down | 8% down | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | CZK 351.5B | CZK 5,475.98 | 2.28% up | 37% up | ||
| 43 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | CZK 207.3B | CZK 8,922.80 | 4.93% down | 24% down | ||
| 44 | PTC TherapeuticsPTCT · Health Care | 9.31% | CZK 111.8B | CZK 1,338.36 | 0.31% down | 20% down | ||
| 45 | Oruka TherapeuticsORKA · Health Care | 9.53% | CZK 143.8B | CZK 2,120.80 | 1.00% down | 241% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | 9.96% | CZK 108.3B | CZK 1,128.29 | 0.72% down | 44% up | ||
| 47 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | CZK 133.4B | CZK 2,043.29 | 0.09% down | 31% up | ||
| 48 | Cogent BiosciencesCOGT · Health Care | 10.0% | CZK 108.1B | CZK 621.53 | 0.34% up | 20% down | ||
| 49 | ErascaERAS · Health Care | 10.6% | CZK 104.3B | CZK 297.14 | 3.82% down | 403% up | ||
| 50 | BridgeBio PharmaBBIO · Health Care | 10.7% | CZK 337B | CZK 1,729.80 | 1.27% up | 17% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | CZK 101.2B | CZK 924.34 | 1.14% down | 88% up | ||
| 52 | AlkermesALKS · Health Care | 11.7% | CZK 174.1B | CZK 1,035.77 | 2.46% up | 58% up | ||
| 53 | Spyre TherapeuticsSYRE · Health Care | 12.2% | CZK 203.4B | CZK 2,141.82 | 2.65% up | 286% up | ||
| 54 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | CZK 133.8B | CZK 6,689.12 | 2.36% up | 43% up | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | CZK 103B | CZK 618.52 | 3.15% up | 64% down | ||
| 56 | CytokineticsCYTK · Health Care | 12.9% | CZK 158.3B | CZK 1,136.08 | 1.10% down | 20% down | ||
| 57 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | CZK 190.3B | CZK 6,809.34 | 0.36% up | 61% up | ||
| 58 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | CZK 182.2B | CZK 2,791.48 | 0.67% up | 46% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | CZK 108.3B | CZK 1,923.41 | 0.57% down | 113% up | ||
| 60 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | CZK 185.4B | CZK 2,674.71 | 3.13% up | 13% up | ||
| 61 | TG TherapeuticsTGTX · Health Care | 19.0% | CZK 221.4B | CZK 1,464.58 | 5.01% up | 107% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2411 CZK).
Questions and answers
Which pharmaceutical companies have the lowest short interest?
Takeda Pharmaceutical (0.10%), AstraZeneca (0.20%) and Novartis (0.24%) have the lowest short interest of the 61 pharmaceutical companies ranked here as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of CZK 112.84T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.